Search Results

Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.

• Authors : Smits JAJ; Institute for Mental Health Research, Department of Psychology, The University of Texas at Austin, Austin.; Pollack MH

Subjects: Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*administration & dosage ; Cycloserine/Cycloserine/Cycloserine/*administration & dosage ; Implosive Therapy/Implosive Therapy/Implosive Therapy/*methods

• Source: JAMA network open [JAMA Netw Open] 2020 Jun 01; Vol. 3 (6), pp. e206777. Date of Electronic Publication: 2020 Jun 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic

Record details

Corneal Deposits in a Patient With Anti-Interferon-γ Autoantibody Syndrome.

• Authors : Ahmad TR; School of Medicine, University of California, San Francisco.; Ashraf DC

Subjects: Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*adverse effects ; Autoantibodies/Autoantibodies/Autoantibodies/*analysis ; Autoimmune Diseases/Autoimmune Diseases/Autoimmune Diseases/*drug therapy

• Source: JAMA ophthalmology [JAMA Ophthalmol] 2020 Mar 01; Vol. 138 (3), pp. 310-311.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print

Record details

Discoloration of intraocular lens subsequent to rifabutin use.

• Authors : Jones DF; Division of Ophthalmology, Fletcher Allen Health Care, UHC Fourth Floor, Burlington, VT 05405.; Irwin AE

Subjects: Lenses, Intraocular* ; Silicone Elastomers*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*adverse effects

• Source: Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2002 Sep; Vol. 120 (9), pp. 1211-2.Publisher: American Medical Association Country of Publication: United States NLM ID: 7706534 Publication Model: Print Cited

Record details

From the Centers for Disease Control and Prevention. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*complications

• Source: JAMA [JAMA] 1996 Nov 20; Vol. 276 (19), pp. 1546.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

Reconsideration of rifampin: a unique drug for a unique infection.

• Authors : Zavasky DM; Sande MA

Subjects: Anti-Bacterial Agents*; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*therapeutic use ; Drug Therapy, Combination/Drug Therapy, Combination/Drug Therapy, Combination/*therapeutic use

• Source: JAMA [JAMA] 1998 May 20; Vol. 279 (19), pp. 1575-7.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.

• Authors : Holmberg SD; Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA.; Moorman AC

Subjects: AIDS-Related Opportunistic Infections/AIDS-Related Opportunistic Infections/AIDS-Related Opportunistic Infections/*prevention & control ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Antibiotics, Antitubercular/Antibiotics, Antitubercular/Antibiotics, Antitubercular/*therapeutic use

• Source: JAMA [JAMA] 1998 Feb 04; Vol. 279 (5), pp. 384-6.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

RESPIRATORY TRACT BACTERIOLOGY IN CYSTIC FIBROSIS.

• Authors : IACOCCA VF; SIBINGA M; BARBERO GJ

Subjects: Anti-Bacterial Agents* ; Antibiotics, Antitubercular* ; Bacteriology*

• Source: American journal of diseases of children (1960) [Am J Dis Child] 1963 Sep; Vol. 106, pp. 315-24.Publisher: American Medical Association Country of Publication: United States NLM ID: 0370471 Publication Model: Print Cited

Record details

Effect of zephiran chloride, tyrothricin, penicillin and streptomycin on ciliary action.

• Authors : GREENWOOD G; PITTENGER RE; et. al.

Subjects: Ammonium Compounds* ; Anti-Bacterial Agents* ; Anti-Infective Agents*

• Source: Archives of otolaryngology [Arch Otolaryngol (1925)] 1946 Jun; Vol. 43 (6), pp. 623-8.Publisher: American Medical Association Country of Publication: United States NLM ID: 9716259 Publication Model: Print Cited

Record details

SEPTICEMIA IN PREMATURE INFANTS. THE CHARACTERISTICS, TREATMENT, AND PREVENTION OF SEPTICEMIA IN PREMATURE INFANTS.

• Authors : BUETOW KC; KLEIN SW; LANE RB

Subjects: Anti-Bacterial Agents* ; Antibiotics, Antitubercular* ; Bacteria*

• Source: American journal of diseases of children (1960) [Am J Dis Child] 1965 Jul; Vol. 110, pp. 29-41.Publisher: American Medical Association Country of Publication: United States NLM ID: 0370471 Publication Model: Print Cited

Record details

Influence of sulfonamide compounds and antibiotics on the future of otolaryngology.

• Authors : McMAHON BJ

Subjects: Anti-Bacterial Agents* ; Antibiotics, Antitubercular* ; Drug Therapy*

• Source: Archives of otolaryngology [Arch Otolaryngol (1925)] 1947 Jan; Vol. 45 (1), pp. 136-8.Publisher: American Medical Association Country of Publication: United States NLM ID: 9716259 Publication Model: Print Cited

Record details